Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
Journal of Clinical Medicine|November 9, 2024
Early Diagnosis of Huntington Disease: Insights from Magnetic Resonance Spectroscopy-A Systematic ReviewPablo S Martínez Lozada, José Duque Perez, Ronney Celi Salinas, et al.Oncotargets and Therapy|July 18, 2018
Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphomaJie Jin, Rumiko Okamoto, Sung-Soo Yoon, et al.Plos One|June 1, 2026
Knowledge about Alzheimer's disease in medical, nursing, and psychology students in Ecuador: A problem that needs an urgent solutionJosé Alejandro Valdevila Figueira, María Alejandra Espinoza de Los Monteros Andrade, Xavier Rodrigo Yambay-Bautista, et al.Prostate International|January 11, 2021
Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 studyHiroji Uemura, Takefumi Satoh, Hideyasu Tsumura, et al.Haematologica|February 11, 2017
Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 studyGregor Verhoef, Tadeusz Robak, Huiqiang Huang, et al.Journal of Neuroinflammation|August 8, 2024
mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytesKun Leng, Brendan Rooney, Frank McCarthy, et al.Journal of Affective Disorders|April 3, 2025
Cross-cultural measurement equivalence of the seven item general anxiety disorder scale (GAD-7) in college students of six countries of Latin AmericanEsteban Moreno-Montero, Rodrigo Moreta-Herrera, Jose A Rodas, et al.Plos One|April 1, 2025
Suicidal behaviour in adolescents with affective disorders: A study in a crisis intervention unit (CIU)José Alejandro Valdevila Figueira, María Alejandra Espinoza de Los Monteros Andrade, Rocío Valdevila Santiesteban, et al.Leukemia & Lymphoma|January 18, 2018
Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 studyJohannes Drach, Huiqiang Huang, Olga Samoilova, et al.JAMA Oncology|June 3, 2021
Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate CancerFelix Y Feng, Shibu Thomas, Fred Saad, et al.Pageof 10